Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

NCT05179889 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Stage III

Interventions

DRUG: mFOLFIRINOX
DRUG: mFOLFOX 6

Sponsor

Chungnam National University Hospital

Collaborators

[object Object]